Results 161 to 170 of about 5,138,444 (292)

Effectiveness and safety of nintedanib in prevention of pulmonary fibrosis induced by bleomycin in malignant ovarian germ cell tumour: study protocol for a randomised, double-blind, placebo-controlled trial. [PDF]

BMJ Open, 2023
Li S, Zhang X, Yin M, Zhang T, Zhang R, Yang J, Yang J.   +6 more
europepmc   +1 more source

Geographical Pattern of Testicular Cancer Points to Maternal Exposures Behind Increasing Incidence

International Journal of Cancer, EarlyView.
ABSTRACT Evidence suggests that testicular cancer (TC) originates from germ cell neoplasia in situ arising during fetal development, implying that prenatal environmental exposures may influence disease risk. We investigated whether maternal place of residence during pregnancy is associated with regional variation in TC incidence.
Antti Kaipia, Karri Seppä, Elli Hirvonen, Eetu Mäkinen, Nea Malila, Janne Pitkäniemi, Jorma Toppari, Peter Boström, Heikki Seikkula   +8 more
wiley   +1 more source

Mixed Germ Cell Tumour in a 58-Year-Old Post-menopausal Woman: A Case Report. [PDF]

Cureus
Okebalama VC, Arisi O, Oragwa D, Ogbodo BM, Omokore O, Ekezie K, Aririsukwu O, Onyemachi E, Oli N, Eke O, Okoronkwo C, Odugbemi O, Odeyinka J, Imafidon E.   +13 more
europepmc   +1 more source

Comparison of Relapse Risk Prediction Models During Active Surveillance in Stage I Seminoma: A Retrospective Multicenter Cohort Study

International Journal of Cancer, EarlyView.
ABSTRACT To improve the prediction of relapse for clinical stage I seminoma, we aimed to validate the Boormans model (incorporating tumor size, rete testis invasion, and lymphovascular invasion) against the conventional classification (tumor size > 4 cm/rete testis invasion).
Andreas Banner, Eveline Daetwyler, Stefanie Fischer, Stephanie Schöpfer‐Schwab, Karl Pemberger, Michael Scholz, Kathrin Olesch, David Oswald, Angelina Strauch, Tim Nestler, Lukas Koren‐Wagner, Robin Zeder, Clemens Mikulits, Sebastian Lenart, Christoph Seidel, Angelika Terbuch   +15 more
wiley   +1 more source

Spontaneous miscarriage after intracytoplasmic sperm injection with frozen sperm of patients with testicular germ cell tumour. [PDF]

BJU Int
Hamada H, Ijuin A, Hayama T, Tsuchiya N, Sueyoshi S, Toda M, Miyakoshi A, Kurumizaka M, Saito M, Oike Y, Ueno H, Kuroda S, Takeshima K, Takeshima T, Saito S, Asano R, Mizushima T, Yumura Y, Sakakibara H, Miyagi E, Tanoshima M, Murase M.   +21 more
europepmc   +1 more source

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

A big catch for germ cell tumour research. [PDF]

PLoS Genetics, 2013
Kenneth S Chen, James F Amatruda
doaj   +1 more source

Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review. [PDF]

Tumori
Francesco P, Caliciotti F, Djaballah SA, Lai E, Bimbatti D, Stragliotto S, Zampiva I, Ballestrin M, Pittarello C, Jubran S, Pretto G, Erbetta E, Milani A, Basso U, Maruzzo M.   +14 more
europepmc   +1 more source

Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour. [PDF]

Eur Urol Open Sci, 2021
Jay APM, Aldiwani M, O'Callaghan ME, Pearce AK, Huddart RA, Mayer E, Reid AH, Nicol DL.   +7 more
europepmc   +1 more source

Hypervision Proton Surgery: The Future Direction of Proton Therapy

iNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source